Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Sara Ciceri"'
Autor:
Sara Ciceri, Alessia Bertolotti, Annalisa Serra, Giovanna Gattuso, Luna Boschetti, Maria Capasso, Cecilia Cecchi, Stefania Sorrentino, Paola Quarello, Chiara Maura Ciniselli, Paolo Verderio, Loris De Cecco, Giacomo Manenti, Francesca Diomedi Camassei, Paola Collini, Filippo Spreafico, Daniela Perotti
Publikováno v:
iScience, Vol 27, Iss 9, Pp 110684- (2024)
Summary: Few studies investigated the genetics of relapsed Wilms tumor (WT), suggesting the SIX1 gene, the microRNA processing genes, and the MYCN network as possibly involved in a relevant percentage of relapses. We investigated 28 relapsing WT pati
Externí odkaz:
https://doaj.org/article/9b08d6b80aba4d31bd8a8bc405f2e82f
Autor:
Sara Ciceri, Andrea Carenzo, Maria Federica Iannó, Alessia Bertolotti, Carlo Morosi, Roberto Luksch, Filippo Spreafico, Paola Collini, Paolo Radice, Maura Massimino, Loris De Cecco, Daniela Perotti
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Intra-tumor heterogeneity (ITH) fosters tumor evolution, resistance to therapy, and relapse. Recently, many evidence have been accumulated on the occurrence of genetic ITH in pediatric cancers. With this study we aimed to address the downstr
Externí odkaz:
https://doaj.org/article/433b0d4ecf2249d2baa958198befd2d2
Publikováno v:
Cell reports. Medicine. 3(6)
In this issue of Cell Reports Medicine, Gadd and colleagues presented on behalf of the Children's Oncology Group their comprehensive analysis of genetic changes associated with relapse in children with favorable histology Wilms tumor.
Autor:
Filippo Spreafico, F Sirchia, Alfredo Brusco, D Carli, Elisa Giorgio, Paola Quarello, Daniela Perotti, Alessandro Mussa, Manuela Spadea, Sara Ciceri, Giovanni Battista Ferrero, Franca Fagioli
Publikováno v:
Pediatric Blood & Cancer. 68
Autor:
Chiara Maura Ciniselli, Paola Quarello, Francesca Diomedi-Camassei, Daniela Perotti, Rafaela Montalvão-de-Azevedo, Rosalin Dolores Spagnuolo, Filippo Spreafico, Paolo Verderio, Annalisa Serra, Mariaclaudia Meli, Sara Ciceri, Anna Maria Buccoliero, Paolo Radice, Angela Tamburini, Luna Boschetti, Paola Collini, Alessia Bertolotti, Amir Tajbakhsh, Maria Capasso, Marilina Nantron, Paolo D'Angelo
Publikováno v:
Cancer gene therapy. 28(9)
Whereas 90% of patients with Wilms tumor (WT) reach cure, approximately half of patients developing a recurrent tumor die of the disease. Therefore, to disclose events leading to recurrence represents a clinical need. To study paired primary/recurren
Autor:
Federica Torri, Filippo Spreafico, Daniela Perotti, Beatrice Gamba, Monica Terenziani, Fabio Macciardi, Paolo Radice, Sara Ciceri, Paola Collini
Publikováno v:
Oncotarget
Approximately half of children suffering from recurrent Wilms tumor (WT) develop resistance to salvage therapies. Hence the importance to disclose events driving tumor progression/recurrence. Future therapeutic trials, conducted in the setting of rel
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Silvia Russo, Paolo Peterlongo, Fabio Pagni, Paola Collini, Chiara Picinelli, Siranoush Manoukian, Gaia Roversi, Sara Ciceri, Bernard Peissel, Milena Crippa, Ilaria Bestetti, Daniela Perotti, Fabiana Saccheri, Pietro Luigi Poliani, Serena Catania, Palma Finelli
Publikováno v:
Scientific Reports
Multiple primary malignant neoplasms are rare entities in the clinical setting, but represent an important issue in the clinical management of patients since they could be expression of a genetic predisposition to malignancy. A high resolution genome
Autor:
Monica Barile, Paolo Peterlongo, Mara Colombo, Anna Falanga, Chiara Corna, Paolo Radice, Fernando Ravagnani, Tiziana Bianchi, Domenico Sardella, Irene Catucci, Sara Ciceri, Paolo Verderio, Bernard Peissel, Graziella Pasquini, Giulietta Scuvera, Laura Galastri, Stefano Fortuzzi, Bernardo Bonanni, Claudia Foglia, Sara Pizzamiglio, Siranoush Manoukian, Loris Bernard, Carlo Tondini, Marina Marchetti
Publikováno v:
Genetics in medicine : official journal of the American College of Medical Genetics. 16(9)
Purpose:Monoallelic germ-line deleterious mutations of PALB2 (partner and localizer of BRCA2) are associated with breast cancer risk and have been found in several populations, with carrier frequencies of ∼1-2%. Initially, these mutations were cons
Publikováno v:
American journal of medical genetics. Part A. (5)